S. aureus, enterotoxins ID'd in atopic keratoconjunctivitis

April 24, 2012
S. aureus enterotoxins ID'd in atopic keratoconjunctivitis

(HealthDay) -- Staphylococcus aureus (S. aureus) and S. aureus-secreted enterotoxins (SE) are frequently found in patients with atopic keratoconjunctivitis (AKC), particularly in those with corneal ulceration, according to a study published online April 10 in Allergy.

Hiroshi Fujishima, M.D., from the Tsurumi University School of in Yokohama, Japan, and colleagues enrolled 18 individuals with AKC, nine with vernal keratoconjunctivitis (VKC), eight with seasonal allergic (SAC), and 10 healthy volunteers to investigate the role of SE in the pathophysiology of AKC. Participants underwent slit lamp examinations, including fluorescein staining. Samples were collected from the skin around the eyelid margins, lower conjunctival sacs, and upper tarsal conjunctiva. Superantigen (SAg) genes were identified using assays.

The researchers found that, compared with VKC patients, SAC patients, and healthy volunteers, S. aureus was detected significantly more in AKC patients. In 11 patients, SAg genes were identified and included SEB (two of 11), SEG (eight of 11), and SEI (eight of 11). SE detection varied significantly between AKC and SAC patients. SE was detected in significantly more patients with corneal ulcers (six of 10) than in patients without corneal ulcers (two of 17).

"S. aureus and SE were frequently found in association with corneal ulceration, suggesting a pathogenic role in the development of ulcers in AKC," the authors conclude.

Explore further: Steroids could help heal some corneal ulcers

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Steroids could help heal some corneal ulcers

October 18, 2011
A UCSF study gives hope to those suffering from severe cases of bacterial corneal ulcers, which can lead to blindness if left untreated. The use of topical corticosteroids in a randomized controlled trial was found to be ...

Long-term use of antibiotic to treat acne not associated with increased bacterial resistance

April 11, 2011
The prolonged use of tetracycline antibiotics commonly used to treat acne was associated with a reduced prevalence of StaphylococcuS. aureus bacteria and was not associated with increased resistance to the tetracycline antibiotics, ...

Low levels of resistant bacteria found in Chicago-area ambulances

March 29, 2012
Treatment areas of ambulances fared well when tested for dangerous bacteria, according to a new study published in the April issue of the American Journal of Infection Control, the official publication of APIC - the Association ...

Recommended for you

New insights into protein's role in inflammatory response

July 28, 2017
A protein called POP2 inhibits a key inflammatory pathway, calming the body's inflammatory response before it can become destructive, Northwestern Medicine scientists have demonstrated in mouse models.

Targeting 'broken' metabolism in immune cells reduces inflammatory disease

July 12, 2017
The team, led by researchers at Imperial College London, Queen Mary University of London and Ergon Pharmaceuticals, believes the approach could offer new hope in the treatment of inflammatory conditions like arthritis, autoimmune ...

A perturbed skin microbiome can be 'contagious' and promote inflammation, study finds

June 29, 2017
Even in healthy individuals, the skin plays host to a menagerie of bacteria, fungi and viruses. Growing scientific evidence suggests that this lively community, collectively known as the skin microbiome, serves an important ...

Inflammatory bowel disease: Scientists zoom in on genetic culprits

June 28, 2017
Scientists have closed in on specific genes responsible for Inflammatory Bowel Disease (IBD) from a list of over 600 genes that were suspects for the disease. The team from the Wellcome Trust Sanger Institute and their collaborators ...

Trials show unique stem cells a potential asthma treatment

June 28, 2017
A study led by scientists at Monash University has shown that a new therapy developed through stem cell technology holds promise as a treatment for chronic asthma.

Researchers find piece in inflammatory disease puzzle

May 23, 2017
Inflammation is the process by which the body responds to injury or infection but when this process becomes out of control it can cause disease. Monash Biomedicine Discovery Institute (BDI) researchers, in collaboration with ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.